Specialty Pharmacy
August 12, 2020
Advances in the Management of Sickle Cell Disease
Three novel agents were recently approved to reduce the incidence of vaso-occlusive pain crises and/or anemia in sickle cell patients.August 12, 2020
Hemophilia Review
August 12, 2020
Guest Editorial: Assuming the Front Line of ADR Reporting
May 15, 2020
A Review of CDK4/6 Inhibitors
March 27, 2020
Shedding Light on Persistent Immune Thrombocytopenia
February 19, 2020
Oral Targeted Therapies for B-Cell Lymphomas
November 25, 2019
Assessing GCSF Agent Guidelines
November 25, 2019
No Added Benefit With Pembrolizumab for Myeloma Versus Standard of Care
November 15, 2019
Managing Common Toxicities Associated With Immune Checkpoint Inhibitors
Copyright © 2000 - 2020 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.